3M™ Kerramax Care™ Border Dressing

  • Options available
  • | Select product options for IDs.

Super-absorbent dressings for absorbing and retaining high levels of exudate1*

Sequesters and retains bacteria and MMPs2*,3* away from the wound bed, preventing the transmission risk of infection

Soft, conformable4

View more details

Details

Highlights
  • Super-absorbent dressings for absorbing and retaining high levels of exudate1*
  • Sequesters and retains bacteria and MMPs2*,3* away from the wound bed, preventing the transmission risk of infection
  • Soft, conformable4
  • Easy to apply4
  • Suitable for use under compression5*

3M™ Kerramax Care™ Dressings are a range of super-absorbent dressings that absorb and retain high amounts of wound exudate1*. The unique wicking layer evenly distributes fluid both horizontally and vertically throughout the dressing, utilizing the full absorption capacity. Exudate is locked away, including bacteria2* and MMPs3*, creating an optimal environment for wound healing, helping to transform patient outcomes.

3M™ Kerramax Care™ Border dressings offer an advanced method of absorbing exudate from wounds utilising Exu-Safe™ technology built into the dressings’ core. This super-absorbent core absorbs and retains moderate to high levels of fluid away from the wound bed protecting delicate wound tissue and surrounding skin whilst helping to reduce the risk of maceration, even under compression. A heat-sealed border prevents leakage whilst a soft, non-woven wound contact layer aids patient comfort.

1 Jackson, S. & Warde, D. Determination of free swell absorption and fluid retention, and absorption capacity under pressure of KERRAMAX CARE™. Crawford Healthcare Ltd. CHC R596. Knutsford, UK: 2017.
2 Singh, G. & Thomason, H. Sequestration and retention of bacteria by superabsorbent dressings over time. KCI. CHC R1043 (in vitro). University of Manchester & KCI Knutsford, UK. 2020.
3 Singh, G. & Thomason, H. Sequestration of matrix metalloproteinases (MMPs) by superabsorbent wound dressings. KCI. CHC R1042 (in vitro). University of Manchester & KCI Knutsford, UK. 2020.
* As demonstrated in vitro

Specifications